资讯

Health And Pharma6 小时
START Doses First Patient in Trial of mRNA-4106, a Pan-Tumor Therapy for Solid Tumors
The START Center for Cancer Research dosed the first patient in Moderna’s Phase 1 trial of mRNA-4106, a multivalent ...
Health And Pharma12 小时
FDA Approves Emrelis as the First Targeted ADC for High c-Met Expressing Lung Cancer
The FDA granted accelerated approval to Emrelis (telisotuzumab vedotin-tllv), the first targeted therapy for previously ...